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Marcelo Cypel, MD, MSc, and Shaf Keshavjee, MD, MScThe number of patients listed for lung transplantation largely exceeds the number of
available transplantable organs because of both a shortage of organ donors and a low
utilization rate of lungs from those donors. A novel strategy of donor lung management – Ex
vivo Lung Perfusion (EVLP) - that keeps the organ at physiological protective conditions
have shown a great promise to increase lung utilization by reevaluating, treating, and
repairing donor lungs prior to transplantation. Clinical trials using EVLP has shown the
method to be safe and allow for reassessment and improvement in function from high risk
donor lungs from both brain death and cardiac death donors prior transplantation. Pre-
clinical studies have also shown a great potential of EVLP as a platform for the delivery of
novel therapies to repair injured organs ex vivo and thus further improve lung
transplantation outcomes. Herein we describe detailed steps for a successful EVLP
procedure.
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General indications for ex vivo lung perfusion (EVLP) arelow oxygenation rates (PaO2/FiO2 o 300 mm Hg),
signs of pulmonary edema on chest x-ray or during
procurement at lung examination, poor lung compliance at
procurement, high-risk clinical history such as history for
aspiration, pneumonia of contra-lateral donor lung, and
controlled donors after cardiac death (DCD) with 460
minutes between withdrawal of life sustaining therapies and
arrest. Some centers would perform EVLP routinely for
donors after cardiac death.1Donor Retrieval Procedure
Donor lung retrieval is performed as routine practice. Careful
mobilization of the lungs is critical during the retrieval to
avoid violation of visceral pleura and subsequent perfusate
leaks during EVLP. The trachea is divided as proximally as
possible (divided just below the larynx) to facilitate secure
intubation in the ex vivo system. Pulmonary artery (PA) and
left atrium (LA) cuffs are left long enough whenever possible
for ex vivo cannulation (Fig. 1A). When cuffs are too short,matter r 2014 Elsevier Inc. All rights reserved.
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.caadditional donor tissue such as aorta, pericardium, or vena
cava can be used to construct neo-cuffs.Priming the Circuit
The circuit is primed with 2 L of Steen Solution (XVIVO
Perfusion, Sweden). This solution is a buffered dextran
containing extracellular-type solution with an optimized
colloid osmotic pressure developed speciﬁcally for EVLP.
Sodium heparin 3000 IU, imipenem 500 mg, and methyl-
prednisolone 500 mg are added to the perfusate.Preparation of Lungs for EVLP
After lung retrieval, the LA appendage is trimmed off and a
specially designed funnel-shaped cannula with a built-in
pressure catheter (XVIVO Perfusion) (Fig. 1B) is sewn to the
LA cuff with a 4-0 monoﬁlament suture to create a closed
circuit. This splints the LA open to create reliable and
consistent outﬂow drainage (Fig. 1C). A speciﬁc PA cannula
with a built-in pressure catheter is used for most cases where
enough length of PA is available for cannulation (Fig. 2A).
This cannula is secured with 0 silk ties (Fig. 2B).
Alternatively, the same funnel-shaped cannula used for LA
cannulation can be used for PA when the cuff is too short.
Note that the silicone part of the cannula can be trimmed to
ﬁt the LA and PA. Next, a back-table retrograde ﬂush is then
performed with 1000 mL of Perfadex (XVIVO Perfusion)
under gravity drainage at 30 cm H20. During this procedure,
perfusate leaks from the LA and PA cannula anastamoses are433
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lungs to the EVLP chamber (XVIVO Perfusion), the trachea
is clamped at the level of the carina to keep the lungs inﬂated
(Fig. 3A) and subsequently the proximal trachea is opened
for intubation. An endotracheal tube (size: 9 mm inner
diameter) is inserted in the trachea and secured circum-
ferentially with an umbilical tape or heavy silk ties (Fig. 3B).
Initiation of EVLP
The lungs are transferred from the back table to the EVLP
chamber placed on a sterile operating room back table
(Fig. 4). First, the LA cannula is connected to the circuit and
slow retrograde ﬂow is initiated to de-air the PA cannula.
Once de-airing is complete, the PA cannula is connected to
the circuit and anterograde ﬂow is initiated at 150 mL/min
with the perfusate at room temperature. At this stage,cannula positions should be checked, and especially a gentle
traction on the LA cannula is applied to assure good patency
of pulmonary veins. It is also important to ensure that PA
and LA pressure readings are reliable to avoid hydrostatic
damage to the lung. The temperature of the perfusate is then
incrementally increased to 371C over the next 30 minutes.
When a temperature of 321C is reached (usually over 20
minutes), ventilation is started and the perfusate ﬂow rate
gradually increased to a target of 40% of predicted cardiac
output (calculated from the size of the lung donor). Then the
ﬂow of EVLP gas used to deoxygenate and provide carbon
dioxide to the inﬂow perfusate via the gas-exchange
membrane is started at 0.5 L/min and titrated to maintain
inﬂow perfusate PCO2 of between 35 and 45 mm Hg.
Recruitment maneuvers to a maximum of 25 cm H2O or 15 mL/
kg (whichever is achieved ﬁrst) are used to recruit regions of lung
atelectasis. Lung overinﬂation should be avoided.
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Figure 1 (A) Lung block prepared for EVLP cannulation. (B-C) Insertion of left atrium cannula. This cannula is anastomosed to left atrium with
a 4.0 prolene running suture.
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Figure 2 Connection of pulmonary artery cannula. The cannula is secured with heavy silk ties.
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Figure 3 Clamping of the trachea prior to intubation.
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Figure 3 Continued.
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Figure 3 Continued.
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Figure 4 Lung block in the EVLP dome.
M. Cypel and S. Keshavjee440
To PA
From LA
Ventilator
Hard shell reservoir
Centrifugal pump
Leukocyte filter
Membrane
gas-exchange
Figure 5 EVLP system.
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A lung-protective strategy of mechanical ventilation is used:
tidal volume of 7 mL/kg; positive end expiratory pressure of
5 cm H2O; respiratory rate of 7 beats/min; and fraction of
inspired oxygen (FiO2) of 21%. Recruitment maneuvers are
performed every hour. As a maintenance perfusate ﬂow rate,
we use 40% of estimated donor cardiac output to perfuse
both lungs.
Most of the lung can be perfused at this ﬂow rate while
generally maintaining acceptable low PA pressures (8-
15 mm Hg). For single lung EVLP, the proportion of 60%
right, and 40% left is used for perfusion ﬂow and ventilation
calculations. LA pressure (LAP) is maintained in the range of
3-5 mm Hg. LAP is controlled by adjusting the height of the
reservoir. The height of the reservoir should be increased if
collapse of LA or pulmonary veins is observed. These
adjustment in reservoir height are needed more often during
the ﬂow ramp-up phase in the ﬁrst hour. Generally LAP
stays stable after achieving full EVLP ﬂows.
Every 1 hour we exchange 250 mL of the perfusate to
maintain glucose levels and to provide fresh perfusate
components.Ex Vivo Lung Functional
Evaluation
Lung function is evaluated every hour in the circuit. At 10
minutes before evaluation, the ventilation settings are
switched to tidal volume of 10 mL/kg, rate of 10 beats/
min, and FiO2 of 100%. The following parameters are then
recorded: oxygenation function PO2/FiO2 (delta PO2 ¼
PO2 perfusate LA  PO2 perfusate PA PO2 [mm Hg]),
pulmonary vascular resistance (PVR ¼ [PAP  LAP] 
80/PA ﬂow [dynes/sec/cm5]), peak airway pressure
(PawP [cm H2O]), airway plateau pressure (Pplat [cm H2O]),
and lung compliance (Cdyn [mL/cm H2O]). General criteria
for acceptability includes a minimum period of 3 hours of
perfusion with stable or improved functional parameters
and a delta PO2 4 350 mm Hg. Alternatively, a criteria of
LA PO2 4 400 mm Hg can be used. Eventually, unilateral
lung injury can account for functional deterioration duringEVLP; in that case, careful assessment with pulmonary vein
gases, lung x-ray, and ﬂexible bronchoscopy can determine
whether the contra-lateral lung can be salvaged for single
lung transplantation.EVLP Termination Phase
After the ﬁnal ex vivo evaluation, the lung block is cooled
down in the circuit to 101C. Thereafter, perfusion and
ventilation are stopped (FiO2 is increased to 50% for lung
storage) and the trachea clamped to maintain the lungs in an
inﬂated state. The lungs are the ﬂushed with 500 mL of fresh
cold Steen solution (some centers use Perfadex instead) and
then stored at 41C in Perfadex until transplantation in a
standard sterile organ bag surrounded by ice. This phase is
called the second cold ischemic time.EVLP System
The components of the EVLP system are detailed in Fig. 5.
The perfusate is circulated by a centrifugal pump passing
through a membrane gas exchanger and a leukocyte-
depletion ﬁlter before entering the lung block through the
PA. A ﬁltered gas line for the gas-exchange membrane is
connected to an H-size tank with a specialty gas mixture of
oxygen (6%), carbon dioxide (8%) and nitrogen (86%)
(Praxair, Mississauga, Ontario, Canada). A heat exchanger is
connected to the membrane gas exchanger to maintain the
perfusate at temperature. PA ﬂow is controlled by the
centrifugal pump and measured using an electromagnetic
ﬂow meter. The outﬂow perfusate returns through the LA
cannula to a hard-shell reservoir. Lungs are ventilated with a
standard intensive care unit–type ventilator. The lungs are
contained in a speciﬁcally designed lung enclosure (XVIVO
Perfusion).Reference
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